1-3 of 3
Donald Thornton, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pronounced Anti-Leukemia Activity in Vivo of the Novel Peptidic CXCR4 Antagonist LY2510924 As a Single Agent and in Combination with Chemotherapy

Byung-Sik Cho, Zhihong Zeng, MD, Hong Mu, MD PhD, Zhiqiang Wang, Teresa McQueen, BS, Marina Protopopova, Jorge E. Cortes, MD, Joe Marszalek, Sheng-Bin Peng, Richard Eric Davis, Donald Thornton, MD, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3745.
https://doi.org/10.1182/blood.V124.21.3745.3745
Published: 2014
Journal Articles

A Phase III Study Of Enzastaurin In Patients With High-Risk Diffuse Large B Cell Lymphoma Following Response To Primary Treatment: The Prelude Trial

Michael Crump, MD FRCPC, Sirpa Leppä, Luis E Fayad, Je-Jung Lee, Alice Di Rocco, MD, Michinori Ogura, MD, PhD, Hans Hagberg, Frederick Schnell, Robert M Rifkin, MD, Andreas Mackensen, Fritz Offner, MD, Lauren Pinter-Brown, MD, Sonali M. Smith, MD, Kensei Tobinai, MD, PhD, Su-Peng Yeh, MD, Jun Zhu, Marjo Hahka-Kemppinen, MD, PhD, Donald Thornton, MD, Peipei Shi, Ph.D., Boris Lin, MD, PhD, Brad S. Kahl, MD, Norbert Schmitz, Kerry J. Savage, MD, MSc, Thomas M Habermann, MD
Journal: Blood
Blood (2013) 122 (21): 371.
https://doi.org/10.1182/blood.V122.21.371.371
Published: 2013
Journal Articles

Phase II Study of Enzastaurin in Patients with Follicular Lymphoma: Updated Final Clinical Results and Immunohistochemical Correlations

Lee Schwartzberg, MD, FACP, Robert Hermann, MD FACP, Ian W. Flinn, MD, PhD, Douglas Flora, MD, Eric D. Hsi, MD, Oday Hamid, Scott P. Myrand, BSc, MSc, MBA, Boris Lin, MD, PhD, Donald Thornton, MD, Peipei Shi, Ph.D., Tuan S Nguyen, Ph.D., Martin Dreyling
Journal: Blood
Blood (2012) 120 (21): 777.
https://doi.org/10.1182/blood.V120.21.777.777
Published: 2012